Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucosamine MAX (G-MAX) is a multi-ingredient dietary supplement developed by Herbcare Corporation, a Philippine-based company specializing in herbal and natural health products. Primarily indicated for joint health and the management of symptoms associated with osteoarthritis, G-MAX typically contains a combination of glucosamine sulfate, chondroitin sulfate, and methylsulfonylmethane (MSM). Glucosamine and chondroitin are structural components of articular cartilage and the extracellular matrix, where they promote the synthesis of proteoglycans and inhibit degradative enzymes. MSM serves as an organic sulfur donor that supports connective tissue repair and exerts anti-inflammatory effects by modulating oxidative stress and cytokine production. The supplement is marketed to improve joint mobility, reduce pain, and slow the progression of cartilage wear in aging or active individuals.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Glucosamine MAX.